A. Riviére
- Oncology top 5%
- Lung Cancer Research Studies 14
- Cancer Treatment and Pharmacology 6
-
- Lung Cancer Treatments and Mutations 14
- Lung Cancer Diagnosis and Treatment 5
- Otorhinolaryngology top 5%
- Dermatology top 10%
-
- Cancer therapeutics and mechanisms 6
-
- Nausea and vomiting management 3
-
- Thin-Film Transistor Technologies 3
- Silicon and Solar Cell Technologies 3
A. Riviére
48 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Oncology 921
- Pulmonary and Respiratory Medicine 828
- Otorhinolaryngology 54
- Dermatology 65
- Hepatology 47
Countries citing papers authored by A. Riviére
This map shows the geographic impact of A. Riviére's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Riviére with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Riviére more than expected).
Fields of papers citing papers by A. Riviére
This network shows the impact of papers produced by A. Riviére. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Riviére. The network helps show where A. Riviére may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Riviére, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 5 | |
| 2 | 2008 | 125 | |
| 3 | 2004 | 31 | |
| 4 | 2002 | 12 | |
| 5 | Looking back or looking all around: comparing two spell checking strategies for documents edition in an electronic patient record. | 2001 | 9 |
| 6 | 2000 | 4 | |
| 7 | 2000 | 9 | |
| 8 | 1998 | 53 | |
| 9 | 1997 | 4 | |
| 10 | 1996 | 1 | |
| 11 | 1994 | 90 | |
| 12 | Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.breakdown → | 1994 | 677 |
| 13 | 1994 | 6 | |
| 14 | 1994 | 21 | |
| 15 | 1994 | 44 | |
| 16 | 1994 | 11 | |
| 17 | Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease. | 1990 | 46 |
| 18 | 1990 | 40 | |
| 19 | 1989 | 12 | |
| 20 | 1987 | 1 |
About A. Riviére
A. Riviére is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Filtration and Separation, Cancer Research and Materials Chemistry, having authored 50 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (14 papers), Cancer therapeutics and mechanisms (6 papers), Cancer Treatment and Pharmacology (6 papers), Lung Cancer Diagnosis and Treatment (5 papers), Nausea and vomiting management (3 papers), Thin-Film Transistor Technologies (3 papers) and Silicon and Solar Cell Technologies (3 papers). The work is most often cited by research in Oncology (921 citations), Pulmonary and Respiratory Medicine (828 citations), Otorhinolaryngology (54 citations), Dermatology (65 citations) and Hepatology (47 citations). A. Riviére has collaborated with scholars based in France, Germany and Belgium. Frequent co-authors include Thierry Le Chevalier, Alain Monnier, Jean‐Yves Douillard, S. Cigolari, P. Lianes, P Chomy, D. Brisgand, Jean Louis Pujol, V. Alberola and Thomas Löning. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, British Journal of Cancer, European Journal of Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.